Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Parul D, Doshi"'
Autor:
Larry E, Kahn, Parul D, Doshi, Kelly L, McGarity, Mingfu, Yu, Christine P, Bono, Wen-Rong, Lie, Anne M, Rankin, Mary L, Smidt, Philip R, Streeter, Barbara K, Klein, Joseph K, Welply, Susan L, Woulfe
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 8(12)
Progenipoietin-4 (ProGP-4) is an E. coli derived chimeric growth factor that activates the human Flt3 and G-CSF receptors. ProGP-4 possesses cross-species activity and treatment of mice with ProGP-4 results in increases in the number of WBC and Class
Autor:
Oussama A, Saleh, William L, Blalock, Carla, Burrows, Linda S, Steelman, Parul D, Doshi, John P, McKearn, James A, McCubrey
Publikováno v:
International journal of molecular medicine. 10(4)
Repopulating hematopoietic cell compartments after myeloablative chemotherapy remains a key factor in a successful chemotherapy program. Modified and chimeric cytokines have been developed to help reduce inflammation, fever and hospitalization time f
Autor:
Jean P. Favara, Larry E Kahn, Judith G. Giri, Michiko S Huynh, Minnerly John C, N.R. Staten, John P. McKearn, Parul D Doshi, Ned R. Siegel, Ann L. Abegg, Doreen Villani-Price, John Warren Thomas, Walter G. Smith, Lyle E. Pegg
Publikováno v:
Experimental hematology. 29(10)
Objective The signaling pathways induced by promegapoietin (PMP), a family of chimeric growth factors that activate the human IL-3 and c-Mpl receptors, were investigated. Methods The biological activity of PMP was examined by receptor binding, cell p
Autor:
M. Pearce, John P. McKearn, C. Burrows, Linda S. Steelman, Parul D Doshi, Oussama A. Saleh, J A McCubrey, W. Smith, P W Moye, William L. Blalock
Publikováno v:
Experimental Hematology. 28:39
The chimeric receptor agonists, myelopoietins (MPOs), bind and activate the human IL-3 and G-CSF receptors while daniplestim binds the human IL-3 receptor with 20-fold higher affinity than native IL-3. In CFU assays using human bone marrow-derived CD
Autor:
Oussama A. Saleh, Parul D Doshi, John P. McKearn, William L. Blalock, C. Burrows, James A. McCubrey, Linda S. Steelman
Publikováno v:
Scopus-Elsevier
ResearcherID
ResearcherID
Repopulating hematopoietic cell compartments after myeloablative chemotherapy remains a key factor in a successful chemotherapy program. Modified and chimeric cytokines have been developed to help reduce inflammation, fever and hospitalization time f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d47971013ebaa55d6894fbeeacf42593
http://www.scopus.com/inward/record.url?eid=2-s2.0-0036782833&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0036782833&partnerID=MN8TOARS